Pain Management of Emergency Laparoscopic Cholecystectomy in Patients With Acute Cholecystitis

Sponsor
Bakirkoy Dr. Sadi Konuk Research and Training Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT03708874
Collaborator
(none)
2
1
5.1
0.4

Study Details

Study Description

Brief Summary

Patients diagnosed with acute cholecystitis benefit from emergency laparoscopic cholecystectomy (LC). Patients who had emergency LC showed improvement in quality of life in one month compared to those treated. Delayed LC (after the acute cholecystitis has passed) and less time to recover from work. This strategy reduces the risk of repeated referrals with more pain or pancreatitis. There are many studies on the efficacy of intraoperative intraperitoneal bupivacaine(IPBV) with elective LC on pain of IPBV. However, the prospective study of reducing the postoperative pain of emergency LC - IPBV is very few. This study will be conducted to evaluate the efficacy of IPBV in patients with emergency LC.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Patients to be included in the study will be selected from the group between 18 and 70 years of age who apply to general surgery and emergency policlinics, depending on patient approval. All patients will be informed about the operation and the procedures to be performed. Patients who accepted to participate in the study will be included in the study and randomization will be performed by randomly selected patients and two groups. The study will be carried out by 2 surgeons with 5 years of laparoscopic cholecystectomy (LC).Adult patients presenting with acute cholecystitis treated by emergency surgeons by one of two surgeons will be included in the study. These two surgeons will be responsible for the participant records. 1.hepatobiliary ultrasound-confirmed acute cholecystitis diagnosis, 2. Patients undergoing elective laparoscopic cholecystectomy (el-LC) will not be included in the study. Patients converted into an open procedure will be excluded from the study. Patients will be divided into two groups. In Group A, intravenous 1 gr paracetamol via will be applied in 30 minutes after waking up.In Group B, immediately after the introduction of intraoperative laparoscopic trocars, 480 ml of saline + 20 ml of 5% bupivacaine solution will be washed in the subdiaphragmatic area, gallbladder region and the entire abdomen. In both groups, standard laparoscopic cholecystectomy will be performed. In both groups, nasogastric tube will be inserted at the end of the operation after intubation. , CRP(C-reactive protein) levels, ALT(Alanine Aminotransferase) , AST(Aspartate Aminotransferase), GGT(Gamma-Glutamyltransferase), total bilirubin, direct bilirubin values will be recorded. Pulse, heart rate, systolic and diastolic pressures, Oxygen saturation (with pulse) during surgery will be recorded in both groups. Post-operative VAS(Visual analogue score) and VRS(Verbal Rating Scales) pain scores will be performed. VAS 0-10 cm and VRS (no pain in cough (score = 0); pain in cough, not in deep breathing (score = 1); resting (score = 2), pain at rest, mild (score = 3); pain at rest, severe (score = 4)) will be evaluated as.

    Study Design

    Study Type:
    Observational [Patient Registry]
    Actual Enrollment :
    2 participants
    Observational Model:
    Other
    Time Perspective:
    Prospective
    Official Title:
    Comparison of Intravenous Paracetamol and Intraperitoneal Bupivacaine for Acute Laparoscopic Cholecystectomy Pain Relief in Patients With Acute Cholecystitis. A Prospective Randomized Clinical Trial
    Actual Study Start Date :
    Oct 9, 2018
    Actual Primary Completion Date :
    Jan 9, 2019
    Actual Study Completion Date :
    Mar 14, 2019

    Arms and Interventions

    Arm Intervention/Treatment
    Group 1.Intraoperative bupivacaine

    intraperitoneal bupivacaine wash-emergency laparoscopic cholecystectomy

    Group 2.Intravenous paracetamol

    intravenous paracetamol-emergency laparoscopic cholecystectomy

    Outcome Measures

    Primary Outcome Measures

    1. Post-operative Shoulder Pain [postoperative 1st day]

      Group 1 and Group 2 Post-operative shoulder pain. VAS score ;Explain to the person that each number describe the intensity of his pain. Number 0 describe very happy and no pain and no hurt at all. Number 1 hurts just a little bit. And as te numbers gradually increase pain will increase. Number 10 describes the worst pain in his life. Ask the patient to choose the number that best describes how he is feeling and his pain.

    Secondary Outcome Measures

    1. Post-operative Abdominal Pain 2nd Hour [pain at postoperative 2nd hour]

      VAS score ;Explain to the person that each number describe the intensity of his pain. Number 0 describe very happy and no pain and no hurt at all. Number 1 hurts just a little bit. And as te numbers gradually increase pain will increase. Number 10 describes the worst pain in his life. Ask the patient to choose the number that best describes how he is feeling and his pain.

    2. operation time [up to 100 minutes]

      duration of operation(minutes), time from anesthesia induction to extubation of the patient

    3. Change in C -reactive protein (CRP) level in all study participants [preoperative and postoperative 1st day]

      Compare the postoperative 1st day CRP levels with the baseline CRP in study patients. Comparison will be performed using a paired t-test.

    4. Change in alanine aminotransferase (ALT) level in all study participants [preoperative and postoperative 1st day]

      Compare the postoperative 1st day ALT levels with the baseline ALT in study patients. Comparison will be performed using a paired t-test.

    5. Change in Aspartate Aminotransferase (AST) level in all study participants [preoperative and postoperative 1st day]

      Compare the postoperative 1st day AST levels with the baseline AST in study patients. Comparison will be performed using a paired t-test.

    6. Post-operative Abdominal Pain 6th Hour [pain at postoperative 6th hour]

      VAS score ;Explain to the person that each number describe the intensity of his pain. Number 0 describe very happy and no pain and no hurt at all. Number 1 hurts just a little bit. And as te numbers gradually increase pain will increase. Number 10 describes the worst pain in his life. Ask the patient to choose the number that best describes how he is feeling and his pain.

    7. Post-operative Abdominal Pain 12th Hour [pain at postoperative 12th hour]

      VAS score ;Explain to the person that each number describe the intensity of his pain. Number 0 describe very happy and no pain and no hurt at all. Number 1 hurts just a little bit. And as te numbers gradually increase pain will increase. Number 10 describes the worst pain in his life. Ask the patient to choose the number that best describes how he is feeling and his pain.

    8. Post-operative Abdominal Pain 24th Hour [pain at postoperative 24th hour]

      VAS score ;Explain to the person that each number describe the intensity of his pain. Number 0 describe very happy and no pain and no hurt at all. Number 1 hurts just a little bit. And as te numbers gradually increase pain will increase. Number 10 describes the worst pain in his life. Ask the patient to choose the number that best describes how he is feeling and his pain.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 70 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Acute stone cholecystitis

    • Acute acrylic cholecystitis

    Exclusion Criteria:
    • Cholecystitis with chronic stones

    • Gallbladder polyps,

    • Patients with bleeding diathesis,

    • Allergy to local anesthetic agents,

    • Patients with paracetamol group allergy,

    • Choledocholithiasis associated with acute cholecystitis

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Turgut Donmez Istanbul Turkey 34300

    Sponsors and Collaborators

    • Bakirkoy Dr. Sadi Konuk Research and Training Hospital

    Investigators

    • Principal Investigator: Turgut Donmez, surgeon, Bakirkoy Training and Research Hospital
    • Study Director: Mehmet Emin Gunes, MD, Bakirkoy Training and Research Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Turgut Donmez, Principal investigator, Bakirkoy Dr. Sadi Konuk Research and Training Hospital
    ClinicalTrials.gov Identifier:
    NCT03708874
    Other Study ID Numbers:
    • BakirköyEAH 2
    First Posted:
    Oct 17, 2018
    Last Update Posted:
    Aug 22, 2019
    Last Verified:
    Aug 1, 2019
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 22, 2019